These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

245 related items for PubMed ID: 16315779

  • 21. Chronic beryllium disease: T cell recognition of a metal presented by HLA-DP.
    Fontenot AP, Newman LS, Kotzin BL.
    Clin Immunol; 2001 Jul; 100(1):4-14. PubMed ID: 11414740
    [No Abstract] [Full Text] [Related]

  • 22. Function associated transforming growth factor-beta gene polymorphism in chronic beryllium disease.
    Gaede KI, Amicosante M, Schürmann M, Fireman E, Saltini C, Müller-Quernheim J.
    J Mol Med (Berl); 2005 May; 83(5):397-405. PubMed ID: 15750822
    [Abstract] [Full Text] [Related]

  • 23. The BeLPT: algorithms and implications.
    Middleton DC, Lewin MD, Kowalski PJ, Cox SS, Kleinbaum D.
    Am J Ind Med; 2006 Jan; 49(1):36-44. PubMed ID: 16362939
    [Abstract] [Full Text] [Related]

  • 24. Racial differences in prevalence of a supratypic HLA-genetic marker immaterial to pre-employment testing for susceptibility to chronic beryllium disease.
    Weston A, Ensey J, Kreiss K, Keshava C, McCanlies E.
    Am J Ind Med; 2002 Jun; 41(6):457-65. PubMed ID: 12173370
    [Abstract] [Full Text] [Related]

  • 25.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 26.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 27. Genetic determinants of sensitivity to beryllium in mice.
    Tarantino-Hutchison LM, Sorrentino C, Nadas A, Zhu Y, Rubin EM, Tinkle SS, Weston A, Gordon T.
    J Immunotoxicol; 2009 Jun; 6(2):130-5. PubMed ID: 19589099
    [Abstract] [Full Text] [Related]

  • 28. Comparative analysis between CFSE flow cytometric and tritiated thymidine incorporation tests for beryllium sensitivity.
    Milovanova TN.
    Cytometry B Clin Cytom; 2007 Jul; 72(4):265-75. PubMed ID: 17328032
    [Abstract] [Full Text] [Related]

  • 29. HLA-DPB1 and chronic beryllium disease: a HuGE review.
    McCanlies EC, Kreiss K, Andrew M, Weston A.
    Am J Epidemiol; 2003 Mar 01; 157(5):388-98. PubMed ID: 12615603
    [Abstract] [Full Text] [Related]

  • 30. Differential susceptibilities to chronic beryllium disease contributed by different Glu69 HLA-DPB1 and -DPA1 alleles.
    Wang Z, White PS, Petrovic M, Tatum OL, Newman LS, Maier LA, Marrone BL.
    J Immunol; 1999 Aug 01; 163(3):1647-53. PubMed ID: 10415070
    [Abstract] [Full Text] [Related]

  • 31. Activation pathways implicate anti-HLA-DP and anti-LFA-1 antibodies as lead candidates for intervention in chronic berylliosis.
    Chou YK, Edwards DM, Weinberg AD, Vandenbark AA, Kotzin BL, Fontenot AP, Burrows GG.
    J Immunol; 2005 Apr 01; 174(7):4316-24. PubMed ID: 15778396
    [Abstract] [Full Text] [Related]

  • 32. Risk of chronic beryllium disease by HLA-DPB1 E69 genotype and beryllium exposure in nuclear workers.
    Van Dyke MV, Martyny JW, Mroz MM, Silveira LJ, Strand M, Fingerlin TE, Sato H, Newman LS, Maier LA.
    Am J Respir Crit Care Med; 2011 Jun 15; 183(12):1680-8. PubMed ID: 21471109
    [Abstract] [Full Text] [Related]

  • 33. Genetic and environmental risk factors in beryllium sensitization and chronic beryllium disease.
    Maier L, Martyny J, Mroz M, McGrath D, Lympany P, duBois R, Zhang L, Murphy J, Newman LS.
    Chest; 2002 Mar 15; 121(3 Suppl):81S. PubMed ID: 11893702
    [No Abstract] [Full Text] [Related]

  • 34. Genetic susceptibility and immune-mediated destruction in beryllium-induced disease.
    Fontenot AP, Maier LA.
    Trends Immunol; 2005 Oct 15; 26(10):543-9. PubMed ID: 16099719
    [Abstract] [Full Text] [Related]

  • 35. Significance of the blood beryllium lymphocyte proliferation test.
    Newman LS.
    Environ Health Perspect; 1996 Oct 15; 104 Suppl 5(Suppl 5):953-6. PubMed ID: 8933041
    [Abstract] [Full Text] [Related]

  • 36. Use of proliferation tests to evaluate the effects of complexing agents on beryllium toxicity.
    Stephan CH, Sauvé S, Fournier M, Brousseau P.
    J Appl Toxicol; 2009 Jan 15; 29(1):27-35. PubMed ID: 18785683
    [Abstract] [Full Text] [Related]

  • 37. Recombinant HLA-DP2 binds beryllium and tolerizes beryllium-specific pathogenic CD4+ T cells.
    Fontenot AP, Keizer TS, McCleskey M, Mack DG, Meza-Romero R, Huan J, Edwards DM, Chou YK, Vandenbark AA, Scott B, Burrows GG.
    J Immunol; 2006 Sep 15; 177(6):3874-83. PubMed ID: 16951350
    [Abstract] [Full Text] [Related]

  • 38. Beryllium-Induced Hypersensitivity: Genetic Susceptibility and Neoantigen Generation.
    Fontenot AP, Falta MT, Kappler JW, Dai S, McKee AS.
    J Immunol; 2016 Jan 01; 196(1):22-7. PubMed ID: 26685315
    [Abstract] [Full Text] [Related]

  • 39. T cell recognition in chronic beryllium disease.
    Amicosante M, Fontenot AP.
    Clin Immunol; 2006 Nov 01; 121(2):134-43. PubMed ID: 16697706
    [Abstract] [Full Text] [Related]

  • 40. The beryllium lymphocyte proliferation test: Relevant issues in beryllium health surveillance.
    Stange AW, Furman FJ, Hilmas DE.
    Am J Ind Med; 2004 Nov 01; 46(5):453-62. PubMed ID: 15490468
    [Abstract] [Full Text] [Related]

    Page: [Previous] [Next] [New Search]
    of 13.